Monitoring agency report for the quarter ended 31st March 2025, in relation to the Public Issue of the Company.
MANBA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Manba Finance has submitted the Monitoring Agency Report from CARE Ratings for the quarter ended March 31, 2025, confirming how the Rs. 150.84 crore raised through its September 2024 IPO was used. Of this, Rs. 130.76 crore was meant to strengthen the company's capital base (as an NBFC) and Rs. 20.08 crore was earmarked for issue expenses. Actual issue expenses came in lower at Rs. 19.65 crore, and the Rs. 0.43 crore saving was redirected into the capital augmentation object, taking the total deployed to Rs. 131.19 crore. The Monitoring Agency confirmed there are no deviations from the objects stated in the offer document, no delays, and no unutilized funds. As the IPO proceeds are now fully utilized, the company stated that no further monitoring agency reports will be required from the next quarter.
This is a routine, positive compliance filing. It confirms that IPO funds were deployed exactly as promised to investors, with a small saving on issue expenses redirected toward the core capital purpose. For shareholders, this signals disciplined fund usage and strengthens the company's NBFC capital base, though it has no direct short-term effect on the stock price.